BIBLIOGRAFIA
1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001, 285, 2370–5. 2. RH., Falk. Atrial Fibrillation. New Engl J Med. 2001, 344, p. 1067-78.
3. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology/american heart association task force on practice guidelines. Circulation. 2006, 114, p. 257-354.
4. Kopecky SL, Gersh BJ, McGoon MD et al. The natural history of lone atrial fibrillation. A population based study over three decades. N Engl J Med. 1987, 317, p. 669-74.
5. Cox JL, Scheusller RB, Boineau JP. The development of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg. 2000, 12, p. 2-14.
6. Bialy D, Lehmann MH, Schumacher DN, et al. Hospitalization for arrhythmias in the United States: importance of atrial fibrillation. J Am Coll Cardiol. 1992, 19, p. 41A.
7. Le Heuzey JY et al. Am Heart J. 2004, 147, p. 121–6. 8. al., Stewart S et. Heart. 2004, Vol. 90, p. 286-92.
9. al., Reynolds MR et. J Cardiovascular Electrophysiology. 2007, 18, p. 628-33.
10. Chen LY, Shen WK. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm. 2007, 4, p. S1–6.
11. Miyasaka Y, BarnesME, Gersh BJ, Cha SS, Bailey KR, AbhayaratnaWP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006, 114, p. 119–25.
12. Wang TJ, Parise H, Levy D, D'Agostino Sr RB,Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004, 292, p. 2471-7.
13. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004, 110, p. 364–7.
14. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003, 107, p. 2589–94.
15. Eaker ED, Sullivan LM, Kelly-Hayes M, D'Agostino Sr RB, Benjamin EJ. Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. 2004, 109, p. 1267–71.
16. Denison H, Jern S, Jagenburg R, Wendestam C, Wallerstedt S. Influence of increased adrenergic activity and magnesium depletion on cardiac rhythm in alcohol withdrawal. Br Heart J. 1994, 72, p. 554–60.
17. Maki T, Toivonen L, Koskinen P, Naveri H, Harkonen M, Leinonen H. Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol-induced atrial fibrillation. Am J Cardiol. 1998, 82, p. 3.
18. Mukamal KJ, Tolstrup JS, Friberg J, Jensen G, Gronbaek M. Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study. Circulation. 2005, 112, p. 1736–42.
19. al., Lloyd-Jones et. Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study. Circulation. 2004, 110, p. 1042-6.
20. Sunil T. Mathew, Jigar Patel, Satheesh Joseph. Atrial fibrillation: Mechanistic insights and treatment options. European Journal of Internal Medicine. 2009, 20, p. 672–681.
21. Weiner P, BassanMM, Jarchovsky J, IusimS, Plavnick L. Clinical course of acute atrial fibrillation treated withrapid digitalization. Am Heart J. 1983, 105, p. 223–7.
22. Levy S, Breithardt G, Campbell RW, Camm AJ, Daubert JC, Allessie M, et al. Atrial fibrillation: current knowledge and recommendations for management. Eur Heart J. 1998, 19, p. 1294–320. 23. Jung F, DiMarco JP. Treatment strategies for atrial fibrillation. Am J Med. 1998, 104, p. 272-86. 24. Moe GK, Abildskov JA. Atrial fibrillation as a self sustaining arrhythmia independent of focal discharge. Am Heart J. 1959, 58, p. 59-70.
25. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998, 339, p. 659–66.
26. Fox CS, Parise H, D'Agostino RB Sr, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA. 16 June 2004, Vol. 291, 23, p. 2851-5.
27. R., Brugada. Molecular biology of atrial fibrillation. Minerva Cardioangiol. 2004, 52, p. 188-199.
28. F. Morady, H. Oral, A. Chugh, F. Pelosi, F. Bogun, E. Good, K. Jongnarangsin, M. Ebinger, and T. Crawford,. The Treatment of Atrial Fibrillation, . [University of Michigan Electrophysiology Service]. July 2009.
29. Dorian, Paul. Rate Control in Atrial Fibrillation. N Engl J Med. 15 April 2010, 362, p. 1439-41. 30. Doty, Donald B. Surgical Treatment of Atrial Fibrillation. Heart Lung and Circulation. 2004, 13, p. 280–287.
31. Nieuwlaat R, Capucci A, Camm AJ, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2005, 26, p. 2422-34.
32. Van Gelder IC, Van Veldhuisen DJ, Crijns HJ, et al. Rate Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure: background, aims, and design of RACE II. Am Heart J. 2006, 152, p. 420-6.
33. Wood MA, Brown-Mahoney C, Kay GN, El lenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation. 2000, 101, p. 1138-44.
34. SM, Narayan. Atrial fibrillation. Lancet. 1997, 350, p. 943-50.
35. Fuster V, Ryden LE. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol. 2001, 38, p. 1231–65.
36. investigators, Wyse DG AFFIRM. Survival in patients presenting with atrial fibrillation: the atrial fibrillation follow-up investigation of rhythm management (AFFIRM). 2002;40:6–7. J Am Coll
Cardiol. 2002, 40, p. 6-7.
37. Stambler BS, WoodMA, Ellenbogen KA, Perry KT,Wakefield LK, VanderLugt JT. Efficacy and safety of repeated doses of ibutilide for rapid conversion of atrial flutter or atrial fibrillation.
Circulation. 1996, 94, p. 1613.
38. McNamara RL, Tamariz LJ, Segal JB, Bass EB. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography.
Ann Intern Med. 16 December 2003, Vol. 12, 139, p. 1018-33.
39. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 30 March 2000, 342, p. 913-20.
40. Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, et al. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med. 5 May 2005, 352, p. 1861-72.
41. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 21 March 1991, Vol. 12, 324, p. 781-8.
42. A. A.V. de Paola, E. Figueiredo, R. Sesso, H. H. Veloso, L. O. T. Nascimento for the SOCESP Investigators,. Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation. International Journal of Cardiology. 2003, 88, p. 157-66.
43. Bianconi L, Mennuni M, Lukic V, Castro A, Chieffi M, Santini M. Effects of oral propafenone administration before cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am
Coll Cardiol. 1996, 28, p. 700-6.
44. Capucci A, Villani G Q, Aschieri D, Rosi A, Piepoli MF. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J. 2000, 21, p. 66-73.
45. HH., Veloso. Effects of oral sotalol administration before electrical cardioversion of persistent atrial fibrillation. Eur Heart J. 2001, 22, p. 1512–4.
46. Detsky AS, Naglie IG. A clinician guide to cost-effectiveness analysis. Ann Intern Med. 1990, 113, p. 147-54.
47. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. October 1998, 339, p. 659-66.
48. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999, 100, p. 1879-1886.
49. Robbins IM, Colvin EV, Doyle TP, Kemp WE, Loyd JE, McMahon WS, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation. 1998, 98, p. 1769 – 1775.
50. Yu WC, Hsu TL, Tai CT, Tsai CF, Hsieh MH, Lin WS, et al. Acquired pulmonary vein stenosis after radiofrequency catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2001, 12, p. 887-892.
51. Haïssaguerre M, Shah DC, Jaïs P, Hocini M, Yamane T, Deisenhofer I, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation. 2000, 102, p. 2463 – 2465.
52. Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M, et al. Complete isolation of left atrium surrounding the pulmonary veins: New insights from the double-lasso technique in paroxysmal atrial fibrillation. Circulation. 2004, 110, p. 2090 – 2096.
53. Mansour M, Ruskin J, Keane D. Efficacy and safety of segmental ostial versus circumferential extra-ostial pulmonary vein isolation for atrial fibrillation. J Cardiovasc Electrophysiol. 2004, 15, p. 532 – 537.
54. Miyazaki S, Kuwahara T, Takahashi A, Kobori A, Takahashi Y, Nozato T, et al. Effect of left atrial ablation on the quality of life in patients with atrial fibrillation. Circ J. 2008, 74, p. 582 – 587. 55. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable micro-reentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation. 2000, 101, p. 194 – 199. 56. Skanes AC, Mandapati R, Berenfeld O, Davidenko JM, Jalife J. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation. 1998, 98, p. 1236 – 1248.
57. Arora R, Verheule S, Scott L, Navarrete A, Katari V, Wilson E, et al. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation. 2003, 107, p. 1816 – 1821.
58. Kumagai K, Ogawa M, Noguchi H, Yasuda T, Nakashima H, Saku K. Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter. J Am Coll Cardiol. 2004, 43, p. 2281 – 2289.
59. Hocini M, Jaïs P, Sanders P, Takahashi Y, Rotter M, Rostock T, et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: A prospective randomized study. Circulation. 2005, 112, p. 3688 – 3696.
60. Verma A, Patel D, Famy T, Martin DO, Burkhardt JD, Elayi SC, et al. Efficacy of adjuvant anterior left atrial ablation during intracardiac echocardiography guided pulmonary vein antrum isolation for atrial fibrillation. J Cardiovasc Electrophysiol. 2007, 18, p. 151 – 156.
61. Arentz T, Weber R, Burkle G, Herrera C, Blum T, Stockinger J, et al. Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study. Circulation. 2007, 115, p. 3057 – 3063.
62. Dixit S, Gerstenfeld EP, Ratcliffe SJ, Cooper JM, Russo AM, Kimmel SE, et al. Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: A prospective randomized study. Heart Rhythm. 2008, 5, p. 174 – 181.
63. Fiala M, Chovancik J, Nevralova R, Neuwirth R, Jiravsky O, Nykl I, et al. Pulmonary vein isolation using segmental versus electroanatomical circumferential ablation for paroxysmal atrial fibrillation: Over 3-year results of a prospective randomized study. J Interv Card Electrophysiol. 2008, 22, p. 13 - 21.
64. Wang XH, Liu X, Sun YM, Shi HF, Zhou L, Gu JN. Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: A prospective randomized study.
Europace. 2008, 10, p. 600 – 605.
65. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ
Arrhythm Electrophysiol. 2010, 3, p. 32 – 38.
66. Oral H, Chugh A, Good E, Wimmer A, Dey S, Gadeela N, et al. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation. 2007, 115, p. 2606 – 2612.
67. Oral H, Chugh A, Good E, Igic P, Elmouchi D, Tschopp DR, et al. Randomized comparison of encircling and nonencircling left atrial ablation for chronic atrial fibrillation. Heart Rhythm. 2005, 2, p. 1165 – 1172.
68. Seow SC, Lim TW, Koay CH, Ross DL, Thomas SP. Efficacy and late recurrences with wide electrical pulmonary vein isolation for persistent and permanent atrial fibrillation. Europace. 2007, 9, p. 1129 – 1133.
69. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006, 354, p. 934 – 941.
70. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, SalibaW, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA. 2005, 293, p. 2634 – 2640.
71. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: The APAF Study. J Am Coll Cardiol. 2006, 48, p. 2340-7.
72. Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation. 2008, 118, p. 2498 – 2505. 73. Forleo GB, Mantica M, De Luca L, Leo R, Santini L, Panigada S, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: Results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2009, 20, p. 22 – 28.
74. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial. JAMA. 2010, 303, p. 333.
75. Hsu LF, Jaïs P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004, 351, p. 2373 – 2383.
76. Ren JF, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation: Identification with intracardiac echocardiography. J Am Coll Cardiol. 2004, 43, p. 1861 – 1867.
77. Cauchemez B, Extramiana F, Cauchemez S, Cosson S, Zouzou H, Meddane M, et al. High-flow perfusion of sheaths for prevention of thromboembolic complications during complex catheter ablation in the left atrium. J Cardiovasc Electrophysiol. 2004, 15, p. 276-283.
78. Ren JF, Marchlinski FE, Callans DJ, Gerstenfeld EP, Dixit S, Lin D, et al. Increased intensity of anticoagulation may reduce risk of thrombus during fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol. 2005, 16, p. 474 – 477.
79. Maleki K, Mohammadi R, Hart D, Cotiga D, Farhat N, Steinberg JS. Intracardiac ultrasound detection of thrombus on transseptal sheath: Incidence, treatment, and prevention. J Cardiovasc
Electrophysiol. 2005, 16, p. 566 – 567.
80. Wazni OM, Rossillo A, Marrouche NF, Saad EB, Martin DO, Bhargava M, et al. Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: Impact of different anticoagulation regimens and importance of intracardiac echo imaging. J Cardiovasc
Electrophysiol . 2005, 16, p. 576-581.
81. Kuwahara T, Takahashi A, Kobori A, Miyazaki S, Takahashi Y, Takei A, et al. Safety and effective ablation of atrial fibrillation: Importance of esophageal temperature monitoring to avoid periesophageal nerve injury as a complication of pulmonary vein isolation. J Cardiovasc
Electrophysiol. 2009, 20, p. 1-6.
82. Takahashi A, Kuwahara T, Takahashi Y. Complications in the catheter ablation of atrial fibrillation: Incidence and management. Circ J. 2009, 73, p. 221 – 226.
83. Spragg DD, Dalal D, Cheema A, Scherr D, Chilukuri K, Cheng A, et al. Complications of catheter ablation for atrial fibrillation: Incidence and predictors. J Cardiovasc Electrophysiol. 2008, 19, p. 627 – 631.
84. Chen YJ, Chen SA. Electrophysiology of the pulmonary veins. J Cardiovasc Electrophysiol. 2006, 17, p. 1080-5.
85. Pappone C, Santinelli V. Safety and efficacy of remote magnetic ablation for atrial fibrillation.
J Am Coll Cardiol. 2008, Vol. 22, 51, p. 1614-5.
86. Van Belle Y, Janse P, Theuns D, Szili-Torok T, Jordaens L. One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation. Europace. 2008, 10, p. 1271-6.
87. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 15 August 2009, Vol. 374, 9689, p. 534-42.
88. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc
Electrophysiol. November 2005, Vol. 16, 11, p. 1160-5.
89. Natale A, Zimerman L, Tomassoni G, Newby K, Leonelli F, Fanelli R, et al. AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: effect on quality of life and exercise performance. Pacing Clin Electrophysiol. November 1999, Vol. 22, 11, p. 1634-9.
90. http://worldwide.espacenet.com. [Online]
91. J.R., Edgerton. Method of treating atrial fibrillation through epicardial lesion. US2011125144 US, 26 May 2011. A1.
92. Oh. Magnetically coupled bipolar radiofrequency ablation catheter. 2011087210 Corea del Sud, 14 April 2011. A1.
93. Bertolero, Ibrahim. CARDIAC ABLATION DEVICES AND METHODS. US2010016851 US, 21 January 2010. A1.
94. Briscoe. Endocardial Dispersive Electrode for Use with a Monopolar RF Ablation Pen.
US2009138008 US, 28 May 2009. A1.
95. Chin. ENDOSCOPE INSTRUMENTS SYSTEMS AND METHODS FOR CLOSED CHEST EPICARDIAL
ABLATION. WO2009088923 US, 16 September 2009. A1.
96. Kunis, Castellano. ATRIAL ABLATION CATHETER AND METHOD OF USE. US2008306477 US, 12 December 2008. A1.
97. Parris, Wellman. SURGICAL TREATMENT FOR ATRIAL FIBRILLATION USING RADIOFREQUENCY
98. Mody, Shroff. A DELIVERY SYSTEM FOR DELIVERING A MEDICAL DEVICE TO A LOCATION
WITHIN A PATIENT'S BODY. WO2008098074 US, 14 August 2008. A2.
99. Sklar, Ring. SYSTEM AND METHOD FOR ADVANCING, ORIENTING, AND IMMOBILIZING ON
INTERNAL BODY TISSUE A CATHETER OR OTHER THERAPEUTIC DEVICE. WO2007123770 US, 1
November 2007. A2.
100. Hooven, Rister. Magnetic catheter ablation device and method. 2005081868 US, 9 September 2005. A2.
101. Scheinman, Kordis. Magnetized electrode tip catheter. 5429131 US, 4 July 1995. 102. Daniel, Harman. Surgical Apparatus. EP0938871 US, 7 March 2001. A3.
103. —. Viewing surgical scope for minimally invasive procedures. US6174307 US, 16 January 2001. B1.
104. al., Faddis et. Magnetic Catheter for Ablation and Mapping. JACC. 3 December 2003, Vol. 42, 11, p. 1952–8.
105. F. Solimene, N. Marrazzo, G. Shopova, G. Donnici, P. Chiariello, P. Rubino, P. Pitrone,. September 2008, Vol. 11, 3.
106. H Nakagawa, Wittkampf, et al. Inverse relationship between electrode size and lesion size during radiofrequency ablation with active electrode cooling. Circulation. 1998, p. 458-65.
107. Kobayashi, et al. Magnetic Anchor for More Effective Endoscopic Mucosal Resection. Jpn J
Clin Oncol. March 2004, Vol. 34, p. 118–123.
108. Troia, Elena. Methodology For Research And Development Of Novel Medical Devices For Minimally Invasive Interventions. 2011. Tesi di dottorato.
109. https://www.hkcm.de/HKCM_demag_data.php?gr=N35&l=. www.hkcm.de. [Online] 110. srl, STEELFLUID. http://www.steelfluid.it. [Online]
